receptor/Fc fusion protein improves hypoxia-induced Pretreatment with a soluble activin type IIB
نویسندگان
چکیده
[PDF] [Full Text] [Abstract] , September , 2010; 109 (3): 635-642. J Appl Physiol Kumar, Kathryn W. Underwood, R. Scott Pearsall and Jennifer L. Lachey Samuel M. Cadena, Kathleen N. Tomkinson, Travis E. Monnell, Matthew S. Spaits, Ravindra independent of fiber type Administration of a soluble activin type IIB receptor promotes skeletal muscle growth [PDF] [Full Text] [Abstract] , April , 2011; 43 (8): 398-407. Physiol. Genomics Louis M. Kunkel and Kathryn R. Wagner Fedik Rahimov, Oliver D. King, Leigh C. Warsing, Rachel E. Powell, Charles P. Emerson, Jr., receptor Gene expression profiling of skeletal muscles treated with a soluble activin type IIB
منابع مشابه
Pretreatment with a soluble activin type IIB receptor/Fc fusion protein improves hypoxia-induced muscle dysfunction.
Hypoxia, or reduced oxygen, occurs in a variety of clinical and environmental situations. Hypoxic exposure is associated with decreased muscle mass and a concomitant reduction in exercise capacity, although the exact mechanisms are not completely understood. The activin type IIB receptor (ActRIIB) is a receptor for transforming growth factor-beta (TGFbeta) superfamily members that are involved ...
متن کاملTreatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy
BACKGROUND Inhibition of activin/myostatin pathway has emerged as a novel approach to increase muscle mass and bone strength. Duchenne muscular dystrophy (DMD) is a neuromuscular disorder that leads to progressive muscle degeneration and also high incidence of fractures. The aim of our study was to test whether inhibition of activin receptor IIB ligands with or without exercise could improve bo...
متن کاملSoluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model
Fractures still present a significant burden to patients due to pain and periods of unproductivity. Numerous growth factors have been identified to regulate bone remodeling. However, to date, only the bone morphogenetic proteins (BMPs) are used to enhance fracture healing in clinical settings. Activins are pleiotropic growth factors belonging to the TGF-β superfamily. We and others have recentl...
متن کاملA Novel Therapeutic Approach to Treating Obesity through Modulation of TGFβ Signaling
Obesity results from disproportionately high energy intake relative to energy expenditure. Many therapeutic strategies have focused on the intake side of the equation, including pharmaceutical targeting of appetite and digestion. An alternative approach is to increase energy expenditure through physical activity or adaptive thermogenesis. A pharmacological way to increase muscle mass and hence ...
متن کاملSystemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes
Doxorubicin is a widely used and effective chemotherapy drug. However, cardiac and skeletal muscle toxicity of doxorubicin limits its use. Inhibiting myostatin/activin signalling can prevent muscle atrophy, but its effects in chemotherapy-induced muscle wasting are unknown. In the present study we investigated the effects of doxorubicin administration alone or combined with activin receptor lig...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2009